Cortexyme

$27.09
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$1.31 (-4.61%) As of 10:47 AM EDT today
-$1.31 (-4.61%) Today

Why Robinhood?

You can buy or sell Cortexyme and other stocks, options, ETFs, and crypto commission-free!

About CRTX

Cortexyme, Inc. Common Stock, also called Cortexyme, is a biopharmaceutical company, which develops therapeutics based on data supporting a new theory of the cause of Alzheimer's and other neurodegenerative disorders. Read More Its product, COR388, is in clinical trial. The company was founded by Casey Crawford Lynch, Stephen Dominy, and Kristen Gafric on June 20, 2012 and is headquartered in South San Francisco, CA.

Employees
19
Headquarters
South San Francisco, California
Founded
2012
Market Cap
762.28M
Price-Earnings Ratio
Dividend Yield
Average Volume
36.42K
High Today
$28.27
Low Today
$27.09
Open Price
$28.27
Volume
15.25K
52 Week High
$47.50
52 Week Low
$17.00

Collections

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.